Search Results - "Dodin, Jamal"
-
1
1120: PROGNOSTIC VALUE OF RED CELL DISTRIBUTION WIDTH IN ACUTE PULMONARY EMBOLISM
Published in Critical care medicine (01-01-2020)Get full text
Journal Article -
2
TCT-694 “Rural” United States Experience of Incorporation of a Technologically Advanced and Procedurally Complex Cardiovascular Program – The Sanford Trans-catheter Aortic Valve Replacement Experience
Published in Journal of the American College of Cardiology (13-10-2015)“…Political, International and Societal Issues Keywords TAVR In-hospital outcome Sanford (n=52) National Registry (n=7710) p-value Death (Any cause) 0 (0%) 427…”
Get full text
Journal Article -
3
Pulmonary Adenocarcinoma Presenting as a Pineal Gland Mass With Obstructive Hydrocephalus
Published in The Ochsner journal (2020)“…Background: Adenocarcinoma is the most prevalent type of non–small cell carcinoma of the lungs. Patients with lung adenocarcinoma often present with cough,…”
Get full text
Journal Article -
4
An Unusual Case of GI Bleeding: Could Histolasmosis be the Culprit?
Published in South Dakota medicine (01-06-2019)“…Gastrointestinal (GI) histoplasmosis is a rare disease with variable manifestations. We report a case of a male patient who developed disseminated…”
Get more information
Journal Article -
5
Brain Tuberculoma: A Case Report and Literature Review
Published in South Dakota medicine (01-07-2017)“…We are reporting on a rare case of central nervous system tuberculosis (TB) in the state of South Dakota. Our case features one of the most infrequent forms of…”
Get more information
Journal Article -
6
Pulmonary Adenocarcinoma Presenting as a Pineal Gland Mass With Obstructive Hydrocephalus
Published in The Ochsner journal (01-01-2020)Get full text
Report -
7
Rural United States Experience of Incorporation of a Technologically Advanced and Procedurally Complex Cardiovascular Program - the Sanford Trans-Catheter Aortic Valve Replacement Experience
Published in South Dakota medicine (01-08-2016)“…Trans-catheter aortic valve replacement (TAVR) was approved by the U.S. Food and Drug Administration in 2012 for treatment of severe symptomatic aortic…”
Get more information
Journal Article